Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Open accessThe DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abstract
Invasive, life-threatening fungal infections are an important cause of morbidity and mortality, particularly for patients with compromised immune function. The number of therapeutic options for the treatment of invasive fungal infections is quite limited when compared with those available to treat bacterial infections. Indeed, only three classes of molecules are currently used in clinical practice and only one new class of antifungal drugs has been developed in the last 30 years. Here we summarize the unmet clinical needs of current antifungal therapy, discuss challenges inherent to antifungal drug discovery and development, and review recent developments aimed at addressing some of these challenges.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Organelles such as the vacuole make important contributions to tolerance and/or trailing growth.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [94]
In the citing paper
“In Saccharomyces cerevisiae several genes involved in retrograde trafficking modulate tolerance and/or trailing growth, including VPS2127,51, VPS15 and VPS5194; Rim101 may influence tolerance via its ability to regulate the transcription of key components of the vacuolar trafficking pathway95.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [94]
In the citing paper
“Despite extensive efforts, target-based cell-free screening of synthetic chemical libraries has failed to deliver any new classes of antifungals or antibacterials in clinical practice (Payne et al., 2007; Roemer and Krysan, 2014).”
From A Fungal-Selective Cytochrome bc1 Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance (2016) · cites this paper as Roemer and Krysan, 2014
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Functional profiling of the Saccharomyces cerevisiae genome
Giaever, G., Chu, A. M., Ni, L., Connelly, C., Riles, L., Véronneau, S., Dow, S., Lucau-Danila, A., Anderson, K., André, B., et al. (2002) · Nature · doi:10.1038/nature00935 · Cited by 4,316
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
The Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162
Park, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N., Pappas, P. G., & Chiller, T. M. (2009) · AIDS · doi:10.1097/qad.0b013e328322ffac · Cited by 2,014
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Pierce, C. G., Uppuluri, P., Tristan, A. R., Wormley, F. L., Mowat, E., Ramage, G., & Lopez-Ribot, J. L. (2008) · Nature Protocols · doi:10.1038/nprot.2008.141 · Cited by 1,041
Amphotericin B formulations: a comparative review of efficacy and toxicity
Hamill, R. J. (2013) · Drugs · doi:10.1007/s40265-013-0069-4 · Cited by 807
Cited by
Items 501–600 of 620
Malavia, D., Leaves, I., Onime, J., O'Neill, P., Yan, K., Brown, A. J., & Gow, N. A. R. (2026) · The Cell Surface · doi:10.1016/j.tcsw.2026.100170 · Cited by 1
Unlocking the potential of cyanobacterial metabolites: Novel antifungal therapies for the future
Kaviraj, M., Jayappriyan, K. R., & Raja, R. (2026) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2026.100609 · Cited by 1
Beyond Antiviral Therapy: Untapped Potential of HIV & HCV Protease Inhibitors
Iuzabchuk, D. A., Andrianova, A. A., Yampolsky, I. V., Kaskova, Z. M., & Smirnov, I. V. (2026) · Medicinal Research Reviews · doi:10.1002/med.70040 · Cited by 1
α-Glucosidase-driven metabolism as a potential therapeutic vulnerability in Candida albicans
Mitra, J., Sajeevan, A., Sujith, S., Paramasivam, S., Shanmugam, K., & Solomon, A. P. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1812644 · Cited by 2
Zhu, L., & Xue, J. Y. (2026) · International Microbiology · doi:10.1007/s10123-026-00830-3 · Cited by 1
Kara, E., Sahin, N., Yumrucu, F. G., & Metan, G. (2026) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-026-02149-5 · Cited by 1
Chedraoui, C., Fattouh, N., Hachem, S. E., Sourenian, T., Bitar, L. E., Moheb, L. E., Sleiman, A., Bitar, I., Husni, R., & Khalaf, R. A. (2026) · Mycoses · doi:10.1111/myc.70181 · Cited by 1
Chen, N., Chi, X., Feng, Q., Zhou, T., Monk, B. C., Tyndall, J. D. A., Jiang, Y., Zhang, D., & Ni, T. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110126 · Cited by 1
Current Promising Therapeutic Targets for Aspergillosis Treatment
Srivastava, S., Maurya, N. S., Kushwah, S., & Mani, A. (2021) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.15.2.09 · Cited by 2
In the Crossroad Between Drug Resistance and Virulence in Fungal Pathogens
Cavalheiro, M., & Teixeira, M. C. (2018) · Springer eBooks · doi:10.1007/978-3-030-00683-9_7 · Cited by 1
Ueno, M., Kobayashi, M., Fujie, A., & Shibata, T. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-0310-9 · Cited by 1
Hsp90 as Drug Target Against Bacterial and Fungal Infections
Islam, M. W., Bloukh, S. H., Edis, Z., & Gacem, S. A. (2020) · Current Chemical Biology · doi:10.2174/2212796814666200309113100 · Cited by 2
Anti-fungal activity of anthraquinone derivatives (Part 1)
Kharlamova, Т. V. (2022) · Chemical Journal of Kazakhstan · doi:10.51580/2022-2/2710-1185.63 · Cited by 1
How Does Bioinformatics Play a Role in Fungal Drug Discovery?
Jaiswar, A., & Rai, N. (2024) · Springer eBooks · doi:10.1007/978-981-99-5696-8_24 · Cited by 2
Agwu, E. (2021) · Special fungal pathogens journal. · doi:10.61915/fpj.556339 · Cited by 2
Prieto, J. M. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001318 · Cited by 1
Functional Genomic and Chemical Biology Analysis of Echinocandin Resistance in Candida albicans
Caplan, T. (2018) · TSpace (University of Toronto) · Cited by 1
The Development of Photo-activated Antimicrobial Dyes Against Opportunistic Infections
Jalab, M. (2020) · CLOK (University of Central Lancashire) · Cited by 1
Shamloo, A. G., Yadegari, M. H., Jaafari, M. R., & Zarrinfar, H. (2023) · Research Square · doi:10.21203/rs.3.rs-3300055/v1 · Cited by 1
Advances in Fungal Infection Research: From Novel Diagnostics to Innovative Therapeutics
Rodrigues, C. F., & Černáková, L. (2025) · Journal of Fungi · doi:10.3390/jof11100693 · Cited by 1
Zeenat, A. R. S., & Zeenat, S. (2015) · DukeSpace (Duke University)
Xie, J. L. (2017) · TSpace (University of Toronto) · Cited by 2
Chacterization of drug resistance mechanisms against antifungal agent Voriconazole
Ercan, İ. (2015) · IYTE GCRIS Database (Izmir Institute of Technology)
Candida albicans adaption to host microenvironments drives immune evasion
Lopes, J. P. (2018) · DiVA (Digitala Vetenskapliga Arkivet)
Willaert, R. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-432-1
Effects of the antimicrobial drug SK-03-92 on Saccharomyces cerevisiae copper-related genes
Amderson, E. I. (2018) · Minds at UW (University of Wisconsin)
Genome mining of rare actinomycetes
Vikeli, E. (2018) · UEA Digital Repository (University of East Anglia)
Neamati, S., Khodavandi, A., & Alizadeh, F. (2019) · Journal of Advances in Medical and Biomedical Research · doi:10.30699/jambs.27.122.1 · Cited by 1
Sangale, D., Tiknaik, A., Khedkar, G. D., Haymer, D. S., Khedkar, C. D., & Tiwari, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.13.093930
To Or Through The Skin: A Rational Design Of Transdermal Drug Delivery
Deaguero, I. G. (2020) · scholarworks - UTEP (The University of Texas at El Paso) · Cited by 1
A Syk/CARD9 szignalizáció szerepe a Candida parapsilosis immunológiai felismerésében
Zajta, E. (2020) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10576
A New Decarboxylase: A Mechanistic Characterization of PrFMN Decarboxylase FDC1
Ferguson, K. L. (2018) · Deep Blue (University of Michigan)
siRNA-Mediated Silencing of Antifungal Resistance Genes: A Research Protocol
Jeong, W., Jeong, S., Wang, K., & Lo, A. (2021) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.292
Santos, L. N., Costa, Â. M. S., Nikolov, M., Sampaio, A. C., Stockdale, F. E., Wangø, G. F., Castillo, H. A., Grizante, M. B., Dudczig, S., Vasconcelos, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.18.469087
Natural Antifungal Products: Another Option for Antifungal Resistance
Hernández‐Castro, R., & Xicohtencatl‐Cortés, J. (2022) · Fungal biology · doi:10.1007/978-3-030-89664-5_16
Combating human fungal infections
Mir, M. A., Qadri, H., Aisha, S., & Shah, A. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96127-1.00010-3 · Cited by 1
Combinatorial approach to combat drug resistance in human pathogenic fungi
Mir, M. A., Qadri, H., Aisha, S., & Shah, A. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96127-1.00011-5
Daman, R., & Sharma, S. (2022) · Oriental Journal Of Chemistry · doi:10.13005/ojc/380317
The Brief Conquest of Infectious Disease
Ehrenreich, J. H. (2022) · SpringerBriefs in psychology · doi:10.1007/978-3-031-04964-4_2
Jafri, H., Samreen, S., Qais, F. A., Abulreesh, H. H., & Ahmad, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-88480-8.00003-0
Hussain, A., & Verma, C. K. (2022) · Letters in Drug Design & Discovery · doi:10.2174/1570180820666221027091852
Aryati, Y. A., & Idrus, E. A. (2022) · MPI (Media Pharmaceutica Indonesiana) · doi:10.24123/mpi.v4i2.5284
A Perspective on Therapeutic Potential of an Invasive Weed, Lantana camara
Monika, M., & Dhingra, N. (2022) · Springer eBooks · doi:10.1007/978-981-19-5779-6_7 · Cited by 3
Challenges and future prospects
Kumar, A., & Jha, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18744-5.00006-x
Duca, M. (2023) · theses.fr (ABES) · doi:10.33540/1692 · Cited by 1
Kaushik, M., Sharma, A., Gupta, S., & Gulati, P. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815080056123020008
Aspergillus and Aspergillosis - Advances in Genomics, Drug Development, Diagnosis and Treatment
Razzaghi‐Abyaneh, M., Rai, M. K., & Shams‐Ghahfarokhi, M. (2023) · Infectious diseases · doi:10.5772/intechopen.107748
Pál, S. E. (2022) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.11334
Aspergilosis: Resistance and Future Impacts
Jorge, A. J. (2023) · Infectious diseases · doi:10.5772/intechopen.112755
Maslennikova, V. S., Miroshnichenko, S. M., Shelikhova, E. V., Tabanyukhov, K. A., Deulin, I. Y., & Пыхтина, М. Б. (2024) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20230616
Microbiologia avançada: perspectivas atuais e futuras
Almeida‐Bezerra, J. W., & Coutinho, H. D. M. (2024) · doi:10.22533/at.ed.164240703
Marques, E. D. L. S., Silva, A. B. D. C. E., & Silva, M. (2024) · doi:10.22533/at.ed.1642407032
Bezerra, C. F., Pereira, S. A. S., Bezerra, M. C. F., Feitosa, V. Q. C., Almeida‐Bezerra, J. W., Morais‐Braga, M. F. B., Siqueira, D. S., Rocha, J. E., Castro, J. W. G., de Oliveira, M. G., et al. (2024) · doi:10.22533/at.ed.1642407033
RESISTÊNCIA DE MICRORGANISMOS: O DESAFIO CONTÍNUO DA ERA PÓS-ANTIBIÓTICOS
Almeida‐Bezerra, J. W., Filho, A. M., Silva, R. L., Novais, M. H. G., Pereira, A. L. G., de Araújo, W. P., Macêdo, M. J. F., Rodrigues, V. L. C., da Silva, N. C., Dunes, C. A. T., et al. (2024) · doi:10.22533/at.ed.1642407031
Girma, A. (2024) · JOURNAL OF COMMUNICABLE DISEASES · doi:10.24321/0019.5138.202360 · Cited by 1
Emerging Saccharomycotina yeast pathogens: Detection and susceptibility profiles
Stavrou, A. A. (2021) · UvA-DARE (University of Amsterdam) · doi:10.5281/zenodo.5558633
Udemezue, O. I., Ezenwelu, C. O., Ikegwuonu, E. A., Udenweze, E. C., & Nwajiobi, F. O. (2024) · International Journal of Science and Research Archive · doi:10.30574/ijsra.2024.11.2.0558 · Cited by 1
Shinggu, J. P., Etim, E. E., Samuel, H. S., & Bako, B. (2024) · Research Square · doi:10.21203/rs.3.rs-4492213/v1
Potential targets for the development of antifungal drugs
Nadeem, A. Y., Shehzad, A., Shahzad, R., Aljafary, M. A., & Al-Suhaimi, E. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18866-4.00013-4
Waykar, R. G., & Kumarapillai, S. (2025) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/zm6uc
Bohner, F. (2024) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.12031
TARGETING IRON ACQUISITION MECHANISMS OF INVASIVE FUNGAL INFECTIONS: OLD AND NEW INSIGHTS
Iași, U., MARIAN, M., Mareș, M., & Iași, U. (2024) · Lucrări Ştiinţifice - Medicină Veterinară, Universitatea de Ştiinţe Agricole şi Medicină Veterinară "Ion Ionescu de la Brad" Iaşi · doi:10.61900/spjvs.2024.03.05
dos Reis, T. F., Delbaje, E., Pinzan, C. F., Bastos, R. W., Ackloo, S. Z., Fallah, S., Laflamme, B., Robbins, N., Cowen, L. E., & Goldman, G. H. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.03318-24 · Cited by 2
Campos, J. C. P., de Oliveira, D. B. C., Souza, B. D. S., de Oliveira, L. F., de Siqueira, E. P., Kohlhoff, M., & Andrade, A. A. (2025) · Canadian Journal of Microbiology · doi:10.1139/cjm-2025-0009
Chattha, G. M., Chattha, M. A., Beys‐da‐Silva, W. O., & Santi, L. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107125 · Cited by 1
Drilling down on treatment-resistant fungi with molecular machines
Santos, A. L., Tour, J. M., & Beckham, J. L. (2023) · The Conversation · doi:10.64628/aai.5au43tcpm
Diffusion-Mediated Quantification of Dose-Dependent Antifungal Drug Tolerance
Koohi, S. R., Galon, C. M., & Charlebois, D. A. (2026) · Biophysical Reports · doi:10.1101/2025.09.05.674536
AI-Driven Revolution in Peptide Classification Landscape
Asim, M. N., Ahmed, S., & Dengel, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-90454-7_6
Antifungal agents from marine microorganisms (bacteria and actinobacteria)
Karthik, T., K., P., Suthindhiran, K., & Jayasri, M. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26771-0.00006-0
Conjugation Based CRISPR Antifungals (COBRA)Preprint
Nasrollahi, V., & Karas, B. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.06.692781 · Cited by 1
Silva, P. J. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.13140/rg.2.2.32107.41765 · Cited by 5
Waykar, R. G., & Kumarapillai, S. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5093812
Massahi, S. (2020) · Spectrum Research Repository (Concordia University)
Feyaerts, A. F. (2019) · Lirias (KU Leuven)
Xue, A. (2022) · TSpace (University of Toronto)
BEZERRA, J. M. D. B. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Sadiq, G. M., Mawhoup, M. A., Tawfik, M. M. M., Mostafa, M., Abdelaziz, A., Yahia, R., El-Baky, R. M. A., Abdel‐Aziz, M., Abuo‐Rahma, G. E. A., & Mohassab, A. M. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109494 · Cited by 1
Christensen, S. M., Kaltenpoth, M., Vogel, H., & Vannette, R. L. (2026) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.007029
Understanding the Antifungal and Antibiofilm Potential of a Naturally Occurring Bacillus Lipopeptide
Madduri, M., Ramesh, S., Samanta, P. P., & Roy, U. (2026) · Apmis · doi:10.1111/apm.70163
Mohammed, M. M., Khodeer, D. M., Al-Razek, M. A., Nabil, Z. I., Orfali, R., & El-Hak, H. N. G. (2026) · Frontiers in Sustainable Food Systems · doi:10.3389/fsufs.2026.1737856
Functional Genomic Analysis of Protein Kinases in the Human Fungal Pathogen Candida albicans
Lee, Y. (2023) · TSpace (University of Toronto)
Development of Fungal-selective Molecules and Strategies to Target Hsp90
LeBlanc, E. V. (2020) · TSpace (University of Toronto)
Thompson, K. M. (2025) · TSpace (University of Toronto)
Wang, Q., Tian, L., Zhou, Z., & Yan, G. (2026) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2026.110119
Etude fonctionnelle et inhibition de la protéine Bdf1 chez Candida albicans
Champleboux, M. (2016) · theses.fr (ABES) · doi:10.70675/07079ce8z25e3z45dfz98e6ze8e3ccbc6182 · Cited by 1
Bioantibio, biosourced antibacterial and antifungal molecules
Dascălu, A. (2019) · theses.fr (ABES) · doi:10.70675/490ff658zea15z4aaezbd90zb1c2d9fdb8fd
Kharrat, O. (2025) · theses.fr (ABES) · doi:10.70675/c47e5b02ze7d4z4d9cz9fd6z03e321b9669f
Fungal Secondary Metabolites as Antibiotics
Bishnoi, S., Rathi, V., Sharma, R. C., Rathi, G., Sohal, J. S., Prakash, A., & Kumar, U. (2026) · Springer eBooks · doi:10.1007/978-3-032-23507-7_3
Fungicides and neurotoxicity: a neglected risk?
Choudhury, D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44287-2.00012-0
Galon, C. M., & Charlebois, D. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.04.730223
A review on thiazole-chalcone conjugates: Diverse and promising pharmacological properties
Bharambe, G. S., Ghodile, N. G., & Kolhe, S. V. (2026) · International Journal of Chemical Studies · doi:10.22271/chemi.2026.v14.i6a.12733
Antifungal resistance: from classical mechanisms to the expanding role of acetyltransferases
Werneck, S. M. C., Gouveia‐Eufrásio, L., de Freitas, G. J. C., de Carvalho, D. S., César, I. C., Rossato, L. L., Bastos, R. W., Peres, N. T. A., & Santos, D. A. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01273-8
Solid-phase synthesis and antimicrobial activities of lipid-neomycin conjugates
Story, S., Bhaduri, S., & Arya, D. P. (2026) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2026.130713
Gaur, N., Parvez, N., & Nagpal, K. (2026) · Toxicology International · doi:10.18311/ti/2026/v33i2/54071
Emerging antifungal agents in human medicine: Mechanisms, clinical progress, and future perspectives
Al‐Zoubi, R. M., Farhan, A., Hanbali, B., Al-Zoubi, S. R., Al-Zoubi, Y. R., Shkoor, M., Alkharraz, L. M., Agouni, A., & Al-Jabiry, A. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119194
Біосинтез амфотерицину В Streptomyces nodosus
Середенко, Є. І. (2022) · Institutional Repository of National University of Food Technologies
Experimental combination therapy against azole-based multidrug resistant Candida auris
Toepfer, S. (2023) · Otago University Research Archive (University of Otago) · Cited by 2
Bhatia, N. M., Kumbhar, S. T., Anbhule, P. J., & Bhatia, M. S. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10928-w
Metadata
- Authors
- Roemer, T., & Krysan, D. J.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- University of Rochester Medicine (US)
- ORCID
- Krysan, D. J.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2014-05-01
- Volume
- 4
- Issue
- 5
- Pages
- a019703-a019703
- ISSN
- 2157-1422 (ISSN-L)
- PMC
- PMC3996373
- OpenAlex
- W2134122507
- Cited by
- 593
- References
- 78
- Citations by year
- 2026: 39 · 2025: 56 · 2024: 69 · 2023: 51 · 2022: 58 · 2021: 68 · 2020: 71 · 2019: 42 · 2018: 50 · 2017: 38 · 2016: 30 · 2015: 18 · 2014: 3
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Rochester
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI097142, R01AI091422)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- antifungal drug development, invasive fungal infections, antifungal drug discovery, unmet clinical needs, immunocompromised patients
- MeSH terms
- Antifungal Agents, Forecasting, Humans, Mycoses, Technology, Pharmaceutical, Treatment Outcome, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.